Biography - Louise Proulx

Dr. Louise Proulx holds a Ph.D. in physiology from Université Laval and pursued postdoctoral studies at the Karolinska Institute in Stockholm. She has close to 30 years experience in research and science management. From 1977 to 1985, she focused her efforts on prostate and breast cancer at the Centre hospitalier de l’Université Laval. From 1985 to 2001, she took over scientific positions of increasing responsibilities, notably as Vice President, Scientific Affairs at Hoechst Marion Roussel Canada, and Vice President, Therapeutic Product Development at Biochem Pharma. She was later Vice President, Business Development of Génome Québec (2001-2002), Vice Principal Research at McGill University (2002-2004) and Vice President, Product Development at Topigen Pharmaceuticals, Inc. (2004-2006). Since December 2006, she is Vice President, Product Development at ViroChem Pharma, Inc.

Dr. Proulx has been a member of several boards of directors over her career and is currently Director of GeminX Pharmaceuticals Inc., Alethia Biotherapeutics, Inc. and Diagnocure Inc. She has also recently been elected to the board of Génome Québec.